Diekema DJ, Hsueh P-R, Mendes RE, Pfaller MA, Rolston KV, Sader HS, Jones RN. The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother. 2019. https://doi.org/10.1128/AAC.00355-19.
Article PubMed PubMed Central Google Scholar
Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods M-C, Peetermans WE. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J. 2007;28:196–203. https://doi.org/10.1093/eurheartj/ehl427.
Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the american heart association. Circulation. 2015;132:1435–86. https://doi.org/10.1161/CIR.0000000000000296.
Article CAS PubMed Google Scholar
Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, et al. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013;56:1261–8. https://doi.org/10.1093/cid/cit052.
Article CAS PubMed Google Scholar
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, et al. ESC guidelines for the management of infective endocarditis: the task force for the management of Infective endocarditis of the European society of cardiology (ESC). endorsed by: European association for cardio-thoracic surgery (EACTS), the European ASSOCIATION of nuclear MEDICINE (EANM). Eur Heart J. 2015. https://doi.org/10.1093/eurheartj/ehv319.
Article PubMed PubMed Central Google Scholar
Antonello RM, Canetti D, Riccardi N. Daptomycin synergistic properties from in vitro and in vivo studies: a systematic review. J Antimicrob Chemother. 2022;78:52–77. https://doi.org/10.1093/jac/dkac346.
Beganovic M, Luther MK, Rice LB, Arias CA, Rybak MJ, LaPlante KL. A Review of combination antimicrobial therapy for enterococcus faecalis bloodstream infections and infective endocarditis. Clin Infect Dis. 2018;67:303–9. https://doi.org/10.1093/cid/ciy064.
Article CAS PubMed PubMed Central Google Scholar
Hemapanpairoa J, Changpradub D, Santimaleeworagun W. Clinical impact of vancomycin treatment in ampicillin-susceptible enterococci bloodstream infections. Antibiotics (Basel). 2022. https://doi.org/10.3390/antibiotics11121698.
Britt NS, Potter EM, Patel N, Steed ME. Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: a national cohort study of veterans affairs patients. Clin Infect Dis. 2015;61:871–8. https://doi.org/10.1093/cid/civ444.
Article CAS PubMed PubMed Central Google Scholar
With K de, Wilke K, Kern WV, Strauß R, Kramme E, Friedrichs A, et al. (2018) S3- Leitlinie “Strategien zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus”. www.awmf.org.
With K de. (2015) Antibiotic Stewardship: Maßnahmen zur Optimierung der antibakteriellen Therapie. [Antibiotic stewardship: Measures for optimization of antibacterial therapy]. Internist. https://doi.org/10.1007/s00108-015-3706-z.
Friedrichs A, Kramme E, Weis S, Pletz M. (2021) Antibiotic Stewardship : Struktur und praktische Umsetzung. [Antibiotic stewardship : Structure and implementation]. Med Klin Intensivmed Notfmed https://doi.org/10.1007/s00063-020-00745-5.
Tebano G, Mouelhi Y, Zanichelli V, Charmillon A, Fougnot S, Lozniewski A, et al. Selective reporting of antibiotic susceptibility testing results: a promising antibiotic stewardship tool. Expert Rev Anti Infect Ther. 2020;18:251–62. https://doi.org/10.1080/14787210.2020.1715795.
Article CAS PubMed Google Scholar
Mohr A, Simon M, Joha T, Hanses F, Salzberger B, Hitzenbichler F. Epidemiology of candidemia and impact of infectious disease consultation on survival and care. Infection. 2020;48:275–84. https://doi.org/10.1007/s15010-020-01393-9.
Vogel M, Schmitz RPH, Hagel S, Pletz MW, Gagelmann N, Scherag A, et al. Infectious disease consultation for Staphylococcus aureus bacteremia - a systematic review and meta-analysis. J Infect. 2016;72:19–28. https://doi.org/10.1016/j.jinf.2015.09.037.
Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, et al. Brief communication: treatment of enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007;146:574–9. https://doi.org/10.7326/0003-4819-146-8-200704170-00008.
Pulcini C, Tebano G, Mutters NT, Tacconelli E, Cambau E, Kahlmeter G, Jarlier V. Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey. Int J Antimicrob Agents. 2017;49:162–6. https://doi.org/10.1016/j.ijantimicag.2016.11.014.
Article CAS PubMed Google Scholar
Langford BJ, Daneman N, Diong C, Marchand-Austin A, Adomako K, Saedi A, et al. Antibiotic susceptibility reporting and association with antibiotic prescribing: a cohort study. Clin Microbiol Infect. 2021;27:568–75. https://doi.org/10.1016/j.cmi.2020.10.001.
Article CAS PubMed Google Scholar
Bourdellon L, Thilly N, Fougnot S, Pulcini C, Henard S. Impact of selective reporting of antibiotic susceptibility test results on the appropriateness of antibiotics chosen by French general practitioners in urinary tract infections: a randomised controlled case-vignette study. Int J Antimicrob Agents. 2017;50:258–62. https://doi.org/10.1016/j.ijantimicag.2017.01.040.
Article CAS PubMed Google Scholar
Coupat C, Pradier C, Degand N, Hofliger P, Pulcini C. Selective reporting of antibiotic susceptibility data improves the appropriateness of intended antibiotic prescriptions in urinary tract infections: a case-vignette randomised study. Eur J Clin Microbiol Infect Dis. 2013;32:627–36. https://doi.org/10.1007/s10096-012-1786-4.
Article CAS PubMed Google Scholar
Heireman L, Vandendriessche S, Coorevits L, Buyle F, de Waele J, Vogelaers D, et al. Effects of cascade reporting of susceptibility profiles for Enterobacterales on broad-spectrum antibiotics use and resistance. Eur J Hosp Pharm. 2022;29:79–83. https://doi.org/10.1136/ejhpharm-2021-002951.
Article PubMed PubMed Central Google Scholar
Zahlanie Y, Hall BC, Wei W, Mang NS, Ortwine JK, Anderson S, et al. Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia. Infect Control Hosp Epidemiol. 2021;42:1272–4. https://doi.org/10.1017/ice.2020.1385.
Article PubMed PubMed Central Google Scholar
Lestin-Bernstein F, Harberg R, Schumacher I, Briedigkeit L, Heese O, Biedermann K. Staphylococcus aureus - selective reporting of antibiogram results and its impact on antibiotic use: interventional study with a reference group on the effect of switching from non-selective to selective antibiotic reporting. Antimicrob Resist Infect Control. 2021;10:157. https://doi.org/10.1186/s13756-021-01021-7.
留言 (0)